press-releases
Lunaphore closes a CHF 23M Series C financing round
Date
![Lunaphore closes a CHF 23M Series C financing round](https://lunaphore.com/wp-content/uploads/2020/02/SERIESC-700x700.png)
Lunaphore Technologies SA, a Swiss life-sciences company developing innovative next-generation equipment for cancer research and tissue diagnostics, announces the first closing of its Series C funding, amounting to CHF 23M. The round was led by the Japanese strategic investor PHC Holdings Corporation, a global healthcare company that owns Epredia, a leading provider of comprehensive solutions for precision cancer diagnostics.